Skip to content

bolivianhealthcares.com

vyprazole-20 injection

VYPRAZOL-20 INJECTION IP

  • Product Name: VYPRAZOL-20 Injection IP

  • Active Ingredient: Rabeprazole 20 mg

  • Form: Injection

  • Uses: Treatment of acid-related disorders like GERD, Zollinger-Ellison syndrome, and peptic ulcers

  • Dosage Form: Intravenous (IV) administration

VYPRAZOL-20 Injection IP is a high-quality proton pump inhibitor (PPI) containing Rabeprazole 20 mg, specially formulated for the treatment of various acid-related gastrointestinal disorders. It works by reducing the production of stomach acid, helping relieve symptoms such as heartburn, acid reflux, and promoting healing of ulcers in the stomach and duodenum.

This injection is ideal for patients who require rapid and effective acid suppression, especially in hospital settings where oral administration may not be feasible. VYPRAZOL-20 ensures faster relief and better management of conditions like Gastroesophageal Reflux Disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers.

Its clinical efficacy, safety profile, and reliable results make it a preferred choice among healthcare professionals for treating acid-related disorders.


Key Benefits

  • Provides rapid and effective relief from acid-related disorders

  • Helps in healing gastric and duodenal ulcers

  • Reduces heartburn, acid reflux, and discomfort

  • Long-lasting acid suppression for better symptom control

  • Safe and clinically tested PPI


How to Use

  • Administered via intravenous (IV) injection under medical supervision

  • Dosage and frequency should be as directed by a healthcare professional

  • Not recommended for self-administration


Why Choose VYPRAZOL-20 Injection IP

  • Contains high-quality Rabeprazole 20 mg, a trusted PPI

  • Clinically tested and hospital-grade formulation

  • Fast-acting and effective in controlling gastric acid

  • Supports healing of ulcers and management of GERD

  • Safe for use under medical guidance


Ingredients

  • Active Ingredient: Rabeprazole 20 mg per injection

  • Excipients: Suitable pharmaceutical carriers for IV use (as per IP standards)